Skip to content
Use caution Medical device recall · FDA · Published December 18, 2017

Terumo Cardiovascular Procedure Kits: Possible Blood Leaks in LeukoGuard Filters

Terumo recalls procedure kits with Pall LG6NS LeukoGuard arterial blood filters due to possible blood leaks. Affected kits may cause bleeding risks during heart surgery. Consumers should contact Terumo for details.

🇺🇸 FDA recall #Z-1314-2018Medical deviceTerumo ›
Take action

Contact the company

Recalling firmTerumo Cardiovascular Systems Corp28 Howe St · Ashland, MA 01721-1305
✎ GovInfoNow plain-language explainer

What happened, in plain English

Terumo is recalling cardiovascular procedure kits that include Pall LG6NS LeukoGuard leukocyte reduction arterial blood filters because these filters might leak blood during use. This could lead to bleeding complications for patients undergoing heart surgery. Read more at govinfonow.com/recall/72299-terumo-cardiovascular-procedure-kits-possible-blood-leaks-in-leukoguard-filters.

Source Summary by GovInfoNow · govinfonow.com/recall/72299-terumo-cardiovascular-procedure-kits-possible-blood-leaks-in-leukoguard-filters · Updated August 31, 2026 · FDA enforcement record: FDA #Z-1314-2018

Cite this page

“Terumo Cardiovascular Procedure Kits: Possible Blood Leaks in LeukoGuard Filters.” GovInfoNow, updated August 31, 2026. https://govinfonow.com/recall/72299-terumo-cardiovascular-procedure-kits-possible-blood-leaks-in-leukoguard-filters. Based on FDA recall #Z-1314-2018 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1314-2018%22&limit=1).

Why it’s dangerous

The Pall LG6NS LeukoGuard filters have a hydrophobic portion that may leak blood during use. This could cause bleeding complications in patients receiving heart surgery through cardiopulmonary bypass procedures.

Who’s affected

Patients undergoing heart surgery using the recalled procedure kits are most at risk. Medical professionals who use these kits for cardiopulmonary bypass procedures may also be affected.

How to tell if you have this one

Check if your kit includes the Pall LG6NS LeukoGuard leukocyte reduction arterial blood filter. The product is sold as a disposable kit for one-time use up to 6 hours.

  • Brand
    Terumo
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Contact Terumo

    Reach out to Terumo for specific instructions on whether your kit is affected and what to do next.

Where it went and when

Where it was distributed

Distributed in 7 states.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: not listedILWisconsin: not listedWIMichigan: not listedMINew York: yesNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: yesOHPennsylvania: not listedPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: not listedCAUtah: not listedUTColorado: not listedCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: yesVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: yesNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: yesALGeorgia: yesGAHawaii: not listedHITexas: not listedTXFlorida: yesFL

FDA distribution: “US Distribution to the states of : AL, OH, VA, NC, GA, NY, FL” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: Alabama, Florida, Georgia, New York, North Carolina, Ohio, Virginia.

Recall timeline

FDA terminated this recall 16 months after the firm started it.

1. Firm started the recall: Dec 18, 201712. FDA classified it Class II: Apr 6, 201823. Published in FDA’s Enforcement Report: Apr 18, 201834. FDA terminated the recall: Apr 9, 2019420172019
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-1314-2018 (December 18, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1314-2018 to see it in context.
  • Plain-language summary written by qwen3:4b on August 31, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA